Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

KRT14 Antikörper (AA 351-472)

Dieses Anti-KRT14-Antikörper ist ein Maus Monoklonal-Antikörper zur Detektion von KRT14 in IHC (f). Geeignet für Human.
Produktnummer ABIN7126627

Kurzübersicht für KRT14 Antikörper (AA 351-472) (ABIN7126627)

Target

Alle KRT14 Antikörper anzeigen
KRT14 (Keratin 14 (KRT14))

Reaktivität

  • 116
  • 75
  • 61
  • 16
  • 6
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Human

Wirt

  • 73
  • 49
  • 2
Maus

Klonalität

  • 63
  • 60
  • 1
Monoklonal

Konjugat

  • 71
  • 7
  • 6
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser KRT14 Antikörper ist unkonjugiert

Applikation

  • 52
  • 50
  • 41
  • 31
  • 26
  • 17
  • 15
  • 13
  • 13
  • 12
  • 11
  • 11
  • 10
  • 2
  • 2
  • 1
  • 1
Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
  • Bindungsspezifität

    • 27
    • 15
    • 13
    • 9
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 351-472

    Spezifität

    Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast.

    Kreuzreaktivität (Details)

    Human.

    Aufreinigung

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    Recombinant fragment (around aa351-472) of human KRT14 protein (exact sequence is proprietary)

    Isotyp

    IgG2
  • Applikationshinweise

    Known_Application: Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95 °C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Positive_Control: Human skin or squamous cell carcinoma tissue.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Konservierungsmittel

    Azide free

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Haltbarkeit

    24 months
  • Target

    KRT14 (Keratin 14 (KRT14))

    Andere Bezeichnung

    KRT14

    Hintergrund

    CK-14, Dowling Meara, ebs3, ebs4, Epidermolysis Bullosa Simplex, Keratin Type I Cytoskeletal 14, Koebner, NFJ,Cytokeratin 14 (KRT14) (Squamous Cell Marker)
    Cellular localisation: Cytoplasmic

    Molekulargewicht

    50kDa

    Gen-ID

    3861, 6545380

    UniProt

    P02533
Sie sind hier:
Chat with us!